Your browser doesn't support javascript.
loading
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.
Clarke, Ed; Saidu, Yauba; Adetifa, Jane U; Adigweme, Ikechukwu; Hydara, Mariama Badjie; Bashorun, Adedapo O; Moneke-Anyanwoke, Ngozi; Umesi, Ama; Roberts, Elishia; Cham, Pa Modou; Okoye, Michael E; Brown, Kevin E; Niedrig, Matthias; Chowdhury, Panchali Roy; Clemens, Ralf; Bandyopadhyay, Ananda S; Mueller, Jenny; Jeffries, David J; Kampmann, Beate.
Afiliação
  • Clarke E; MRC Unit The Gambia, Fajara, Banjul, The Gambia. Electronic address: eclarke@mrc.gm.
  • Saidu Y; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Adetifa JU; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Adigweme I; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Hydara MB; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Bashorun AO; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Moneke-Anyanwoke N; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Umesi A; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Roberts E; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Cham PM; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Okoye ME; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Brown KE; Virus Reference Department, Public Health England, Colindale, UK.
  • Niedrig M; Centre for Biological Threats and Special Pathogens, Robert Koch Institut, Berlin, Germany.
  • Chowdhury PR; Centre for Biological Threats and Special Pathogens, Robert Koch Institut, Berlin, Germany.
  • Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil.
  • Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, USA.
  • Mueller J; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Jeffries DJ; MRC Unit The Gambia, Fajara, Banjul, The Gambia.
  • Kampmann B; MRC Unit The Gambia, Fajara, Banjul, The Gambia; Department of Medicine, Imperial College, London, UK.
Lancet Glob Health ; 4(8): e534-47, 2016 08.
Article em En | MEDLINE | ID: mdl-27364568
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Poliomielite / Rubéola (Sarampo Alemão) / Vacina Antipólio de Vírus Inativado / Estudos Soroepidemiológicos / Vacinas Combinadas / Vacina contra Febre Amarela / Sarampo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Glob Health Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Poliomielite / Rubéola (Sarampo Alemão) / Vacina Antipólio de Vírus Inativado / Estudos Soroepidemiológicos / Vacinas Combinadas / Vacina contra Febre Amarela / Sarampo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Glob Health Ano de publicação: 2016 Tipo de documento: Article